|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| 2023 | Avivagen Inc. Announces New 500 Kg Order for OxC-beta | CI |
| 2023 | Avivagen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 | CI |
Avivagen Inc. reported earnings results for the first quarter ended January 31, 2023. For the first quarter, the company reported sales was CAD 0.066039 million compared to CAD 0.271157 million a year ago. Net loss was CAD 1.15 million compared to CAD 1.55 million a year ago.
Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.03 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 284K | |
| +11.33% | 11.43B | |
| -0.75% | 5.77B | |
| -4.08% | 4.87B | |
| -5.10% | 4.14B | |
| -23.66% | 2.58B | |
| -5.06% | 1.75B | |
| -24.53% | 1.11B | |
| -18.46% | 865M | |
| +24.67% | 855M |
AVIVAGEN INC. 
